Condition

Type 2 Diabetes Mellitus in Obese

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 24 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials24
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

24 shown
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With SemaglutideNCT06497595 · 2025-05-11
RECRUITING
Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell FunctionNCT06682481 · 2024-11-22
RECRUITING
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus ParticipantsNCT05838287 · 2023-07-10
RECRUITING
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)NCT05277558 · 2022-05-24
RECRUITING
Implementation of a Peer Leader-facilitated Dyadic InterventionNCT06643806 · 2025-03-20
COMPLETED
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual DifferencesNCT06442150 · 2024-06-01
NOT_YET_RECRUITING
Effect of Cryolipolysis on Insulin ResistanceNCT06223490 · 2023-11-01
UNKNOWN
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMNCT06005012 · 2023-07-25
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 DiabetesNCT05890950 · 2023-03-13
COMPLETED
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)NCT05770076 · 2023-02-01
COMPLETED
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal MedicineNCT05072990 · 2021-10-27
COMPLETED
Glucagon-like Peptide-1 Agonism With Very Low Calorie DietsNCT05606471 · 2021-09-15
UNKNOWN
The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic AdultsNCT04931836 · 2021-07-29
COMPLETED
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62NCT05409027 · 2021-07-23
COMPLETED
Effect of Subcutaneous Semaglutide on Kidney Transplant CandidacyNCT04741074 · 2021-07-23
TERMINATED
REmote SUpport for Low-Carbohydrate Treatment of Type 2 DiabetesNCT04916314 · 2021-07-01
COMPLETED
Heart Rate Variability-Guided Exercise Training in Type 2 DiabetesNCT04910997 · 2021-06-01
WITHDRAWN
Phentermine/Topiramate for Uric Acid StonesNCT04621929 · 2021-03-31
COMPLETED
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBPNCT05446415 · 2020-02-05
UNKNOWN
The Effect of Exenatide on Fasting Bile AcidsNCT04303819 · 2020-01-05
COMPLETED
Effect of a Plant Rich Diet on in People With Type 2 Diabetes and ObesityNCT02977039 · 2019-11-01
WITHDRAWN
Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric DietNCT04363710 · 2017-05-31
COMPLETED
Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic PatientsNCT02937987 · 2016-04-01
COMPLETED
Glycemic Profile by CGMS in Diabetic Patients After Bariatric SurgeryNCT04332354 · 2016-03-30
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED12
RECRUITING4
UNKNOWN3
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
TERMINATED1

Phase mix

NA11
PHASE12
PHASE22
PHASE42
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.